Clinical studies have shown the upregulation of a DNA oxidation marker, 8-OHdG, in the blood, aqueous humor, and TM from POAG patients [393]
Currently, two clinical trials are underway to assess its safety, tolerability, and efficacy (NCT04471415, NCT06027086)
Give yourself a realistic goal
not recommended for children and pregnant women (caffeine content 18 mg in 1 serving)
Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
Amlodipine rescues a patient with IOC due to primary hemochromatosis A 69-year-old man with a history of primary hemochromatosis (PH) (C282Y/H63D compound heterozygote) and myelodysplastic syndrome (MDS) presented with IOC leading to HF and conduction abnormalities